DuPont (DD)
Materials · Specialty Chemicals · NYSE
A streamlined materials science firm navigating a major portfolio transformation and legacy environmental liabilities.
What DuPont does
DuPont de Nemours, Inc. is a global materials science company that has recently undergone a major portfolio transformation, divesting its electronics, semiconductor, and aramid fiber businesses. The company focuses on developing science-based solutions across various industrial, construction, and consumer applications. Following these divestitures, DuPont continues to manage legacy liabilities, most notably those related to per- and polyfluoroalkyl substances (PFAS).
Themes: materials science, corporate restructuring, environmental remediation / PFAS liability, divestitures
Fundamentals
- Price$138.33 as of 2026-08-21 close
- Market cap$18.7B as of 2026-08-21
- 1-year return+47.7% 2025-08-21 close $93.67 → 2026-08-21 close $138.33
- P/E353.30 as of 2026-08-24
- Net margin+0.7% as of 2026-08-24
- Gross margin+36.7% as of 2026-08-24
- ROE+0.3% as of 2026-08-24
- Debt / equity0.23 as of 2026-08-24
- Revenue growth (YoY)-34.4% as of 2026-08-24
- Revenue CAGR (3y)-19.3% SEC XBRL
- Beta1.04 as of 2026-08-24
- Last reported earnings2026-08-04 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +2.0%; 1-year non-decreasing per-share dividend streak (SEC XBRL).
How DD compares in its sector
- price-to-earnings ratiotop 10% 94 covered Materials peers, as of 2026-08-24
- net profit marginmiddle range 142 covered Materials peers, as of 2026-08-24
- operating marginmiddle range 142 covered Materials peers, as of 2026-08-24
- gross margintop 25% 141 covered Materials peers, as of 2026-08-24
- return on equitymiddle range 151 covered Materials peers, as of 2026-08-24
- 3-year revenue CAGRbottom 10% 127 covered Materials peers
- indicated dividend yieldmiddle range 95 covered Materials peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)middle range 124 covered Materials peers, as of FY2025
Position among covered Materials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
DD is not currently in any published Top 10 list. Its scores are below.
Long-term score
33.1 #928 of 987 scored · #57 of 66 in Materials
Financial health 66th (debt to equity 0.2, free cash flow margin 12.7%) and long-term trend 59th (over the past 12 months this stock beat the market by 27.2 percentage points); weakest is growth (1st, 3-year revenue CAGR -19.3%, revenue growth year over year -34.4%).
Short-term score
54.9 #487 of 1,704 scored · #25 of 83 in Materials
Setup 73rd: no fresh 20-day breakout up or down; volume and participation 66th: trading volume is about normal versus its 30-day average; weakest is momentum 37th: over the past 3 months this stock lagged the market by 5.4 percentage points.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Exceeded at least one reported measure. In FY2025, DD's dividend exceeded at least one reported measure of what it earned or generated (free-cash-flow payout 263%). A payout above 100% in one year is not necessarily unsustainable, but it is not fully covered by that measure.
- Earnings payoutnot assessable earnings were not positive that year
- Free-cash-flow payout263% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How DuPont looks technically
DuPont (DD) is trading 2.2% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 239 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 9, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 45, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 4 trading days ago (its momentum flipped negative). It made a new 20-day high about 13 trading days ago.
Trend
7
| Distance from the 200-day | it is trading 2.2% above its 200-day average, the long-term trend line — a longer-term uptrend | +2.2% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $139.70 | $139.70 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $135.41 | $135.41 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 239 trading days ago — a "golden cross", a bullish long-term signal | 239 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 9, below the 25 that marks a real trend) | 9.4 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 45, neither overbought (above 70) nor oversold (below 30) | 44.8 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($130.19 to $149.34) — its "stochastic" reading is 43 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 42.5 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 4 trading days ago (its momentum flipped negative) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $158.14 | $158.14 |
|---|---|---|
| From the 52-week high | it is 12.5% below its 52-week high (its highest price of the past year) | -12.5% |
| Above the 52-week low | it is 51.2% above its 52-week low (its lowest price of the past year) | +51.2% |
| Below the 52-week high | it is 12.5% below its highest point of the past year | 12.5% |
| Since a 20-day breakout | it made a new 20-day high about 13 trading days ago | 13 sessions |
| Since a 55-day breakout | it made a new 55-day low about 30 trading days ago | 30 sessions |
| All-time high | its highest closing price on record is $158.14 (set on 2026-02-12) | $158.14 |
| Given back of the 52-week move | over the past year its closes ranged ($91.96 to $154.74), and it has given back roughly a quarter of its rise from last year’s low — 26% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $113.94 to $115.95. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 26.1% |
| From the all-time high | it is 12.5% below its all-time high | -12.5% |
| Nearest price level | it is trading 2.7% above a support level at $134.57 — a price it turned at twice since 2026-04-29, most recently on 2026-06-11. Since 2024-08-21 it has 14 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -2.7% |
| All-time low | its lowest closing price on record is $7.79 (set on 1982-08-09) | $7.79 |
| Above the all-time low | it is 1675.5% above its all-time low | +1,675% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 78% of it) | 22nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $3.72 between its high and its low — about 2.7% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $3.72 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $135.86 and $147.33 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $135.86 – $141.59 – $147.33 |
| Typical daily range (% of price) | its price moves about 2.7% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.7% |
| Stretch from the 200-day average | it is trading 0.8 daily ranges above its 200-day average price (2.2% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.8 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.96× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 0.1% since the prior reading | +0.1% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|---|---|
| Since a bullish engulfing | 5 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 5 sessions ago |
Price gaps
2
| Gap at the open | it opened on 2026-08-21 1.1% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +1.1% |
|---|---|---|
| Gap filled | a 7.9% gap down opened on 2026-08-04 has been "filled" 13 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 13 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -0.97% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 2.7 percentage points (the stock lost 0.3% while the market gained 2.3%) | -2.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 5.4 percentage points (the stock lost 2.3% while the market gained 3.1%) | -5.4% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 19.7 percentage points (the stock lost 8.6% while the market gained 11.1%) | -19.7% |
| vs market, 12 months | over the past 12 months this stock beat the market by 27.2 percentage points (the stock gained 47.7% while the market gained 20.5%) | +27.2% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: MACD momentum is negative, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 0.1% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 3.4% of the share price. | -0.1% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 1% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $140.04 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | -1.2% |
|---|---|---|
| Vs the average paid since it last reported | the price is 3% below the average price paid since it last reported on 2026-08-04 (its 10-Q), so the typical buyer over that stretch is under water. That average is $142.63 — a volume-weighted average of daily closes over 14 sessions, not a true tick-by-tick VWAP. | -3.0% |
Price levels it has turned at before
DD last closed at $138.33 on 2026-08-21. Since 2024-08-21 it has turned at 14 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $134.57 | Support | 2.7% below the last close | turned there twice · 2026-04-29 to 2026-06-11 |
| $144.59 | Resistance | 4.5% above the last close | turned there twice · 2026-04-09 to 2026-04-17 |
| $130.45 | Support | 5.7% below the last close | turned there five times · 2026-01-30 to 2026-08-04 |
| $148.26 | Resistance | 7.2% above the last close | turned there three times · 2026-06-17 to 2026-08-14 |
| $125.39 | Support | 9.3% below the last close | turned there five times · 2025-11-12 to 2026-03-20 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · MACD just crossed bearish (12/26/9) · trendless / choppy (low ADX) · lagging the market · Trading at this year’s average price paid (anchored VWAP) · Under water since its last earnings report (below the anchored VWAP) | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.59 mean, 1=Strong Buy…5=Strong Sell) — 16 analysts
- Mean price target$170.00 range $156.00 – $186.00; median $171.00
Analyst estimates, as of 2026-08-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for DD
- Consensus EPS estimate$1.90 next reporting period, as of 2026-08-19
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Significant and ongoing legal, financial, and regulatory risks associated with legacy PFAS and PFOA liabilities and environmental remediation obligations.","Execution risks related to the successful integration of recent organizational restructurings and the realization of anticipated operational synergies.","Exposure to global economic volatility, geopolitical tensions, and trade restrictions that impact supply chains and raw material costs."]
What changed in the latest 10-Q
AI-assisted comparison of DD's 10-Q filed 2026-05-05 against the prior one filed 2025-11-06.
Management's Discussion & Analysis (MD&A)
- Added:
- Added description of Aramids Divestiture completed April 1, 2026 with cash proceeds of approximately $1.2 billion, note receivable of $300 million, and equity consideration of $325 million in Arclin (filed 2026-05-05)
- Added statement that Aramids divested business results are reflected as discontinued operations (filed 2026-05-05)
- Added description of Electronics Separation completed November 1, 2025 into Qnity Electronics, Inc. with distribution date of November 1, 2025 (filed 2026-05-05)
- Added statement that Electronics Business results for three months ended March 31, 2025 are reflected as discontinued operations (filed 2026-05-05)
- Added macroeconomic development regarding February 2026 Middle East military conflict involving United States, Israel, and Iran, noting Company has no operations in Iran and conflict has not had material impact to date (filed 2026-05-05)
- Removed:
- Removed reference to September 30, 2025 working capital of $3.5 billion and cash of approximately $2.0 billion (filed 2025-11-06)
- Removed statement that DuPont is 'a global innovation leader' and reference to 'transportation, and electronics' as key markets (filed 2025-11-06)
- Removed 'Qnity Spin-Off' section describing November 1, 2024 completion date and pro rata distribution mechanics (filed 2025-11-06)
- Removed 'Aramids Divestiture' section describing August 29, 2025 announcement of definitive agreement and $1.8 billion valuation subject to closing conditions (filed 2025-11-06)
- Removed 'New Jersey Settlement Agreement' section describing August 2025 proposed Judicial Consent Order with State of New Jersey regarding DNAPL, chemical solvents, and PFAS claims (filed 2025-11-06)
- Removed macroeconomic section describing U.S. government trade actions, tariffs on Canada, Mexico, China, and potential impacts on competitiveness and sales (filed 2025-11-06)
- Reworded:
- Changed company description from 'a global innovation leader, providing advanced solutions that help transform industries and improve everyday life' to 'a leading provider of advanced solutions that improve everyday life' (filed 2026-05-05)
- Changed market description from 'key markets including healthcare, water, construction, transportation, and electronics' to 'healthcare, water, construction and industrial markets' (filed 2026-05-05)
- Changed working capital statement to reflect 'As of March 31, 2026' date with '$2.0 billion' instead of 'As of September 30, 2025' with '$3.5 billion' (filed 2026-05-05)
- Changed cash and equivalents statement to reflect 'approximately $0.7 billion' instead of 'approximately $2.0 billion' (filed 2026-05-05)
- Changed section heading from 'recent developments and material historical transactions' to 'material historical transactions and recent developments' (filed 2026-05-05)
- Notes:
- Comparison reflects different fiscal quarter end dates: March 31, 2026 (newer) versus September 30, 2025 (older), which impacts financial metrics and development timing
- The older filing references events as pending or announced (e.g., Qnity spin-off as 'subsequent to quarter end'), while newer filing reports these as completed transactions
Risk Factors
- Added:
- Added April 1, 2026 completion date for Aramids Business sale to Arclin (filed 2026-05-05)
- Added description of Aramids Equity Consideration as non-controlling common equity interest valued at $325 million in New Arclin U.S. Holding Corp. (filed 2026-05-05)
- Added March 18, 2026 announcement of planned Intended Reverse Stock Split at ratio of 1-for-2 to 1-for-4, subject to stockholder approval (filed 2026-05-05)
- Added statement that interim Consolidated Financial Statements have not been retrospectively adjusted to reflect Intended Reverse Stock Split (filed 2026-05-05)
- Added November 1, 2025 Electronics Separation completion date and renamed 'Distribution' as 'Qnity Distribution' (filed 2026-05-05)
- Added Item 3. Defaults Upon Senior Securities in table of contents (filed 2026-05-05)
- Added reference to Exchange Act in forward-looking statements language (filed 2026-05-05)
- Added forward-looking statement risk factor (x) regarding ability to implement and realize benefits of Intended Reverse Stock Split (filed 2026-05-05)
- Added forward-looking statement risk factor (xi) regarding impact of invalidation of certain tariffs imposed under International Emergency Economic Powers Act (filed 2026-05-05)
- Removed:
- Removed discussion of Q1 2025 Segment Realignment and its details (filed 2025-11-06)
- Removed discussion of Q4 2025 Segment Realignment and statement that it would be reflected in 2025 Annual Report on Form 10-K (filed 2025-11-06)
- Removed statement that Aramids Divestiture is 'expected to close in the first quarter of 2026' and phrase 'subject to customary closing conditions and receipt of regulatory approvals' (filed 2025-11-06)
- Removed phrase 'beginning in the fourth quarter of 2025' regarding when financial results will be reflected (filed 2025-11-06)
- Removed phrase 'beginning in the third quarter of 2025' regarding when Aramids business financial results were reflected (filed 2025-11-06)
- Removed forward-looking statement risk factor regarding 'DuPont's success in achieving its intended post-Electronics Separation capital structure' (filed 2025-11-06)
- Removed phrase 'the ability to timely effect, if at all, the Aramids Divestiture and' from forward-looking statements (filed 2025-11-06)
- Removed phrase 'or restrictions' and replaced with 'or restrictions or restrictions' in tariffs risk factor (filed 2025-11-06)
- Reworded:
- Changed 'announced a definitive agreement to sell the Aramids business' to 'completed the sale of the Aramids Business' (filed 2025-11-06 vs 2026-05-05)
- Changed description of transaction counterparty from 'TJC LP' to 'Arclin, a portfolio company of an affiliate of TJC LP' (filed 2025-11-06 vs 2026-05-05)
- Changed 'in return for cash proceeds' to 'for pre-tax cash proceeds' (filed 2025-11-06 vs 2026-05-05)
- Changed 'a note from TJC' to 'a note receivable' (filed 2025-11-06 vs 2026-05-05)
- Changed 'minority equity interest' to 'non-controlling common equity interest' (filed 2025-11-06 vs 2026-05-05)
- Changed 'the future Arclin holding company' to 'New Arclin U.S. Holding Corp.' (filed 2025-11-06 vs 2026-05-05)
- Changed 'the Electronics Separation and Distribution' to 'the Electronics Separation and the Qnity Distribution' (filed 2025-11-06 vs 2026-05-05)
- Changed '$2 billion share buyback authorization DuPont announced on November 6, 2025' to '$2 billion share buyback announced on November 6, 2025 (the "$2B Authorization")' (filed 2025-11-06 vs 2026-05-05)
- Changed 'timelines' to 'timeline' in buyback risk factor (filed 2025-11-06 vs 2026-05-05)
- Changed 'continuing or expanding trade disputes' to 'continuing or expanding geopolitical conflicts or trade disputes' (filed 2025-11-06 vs 2026-05-05)
- Changed 'including on exports' to 'including on exports to China of U.S.-regulated products and technology' (filed 2025-11-06 vs 2026-05-05)
- Notes:
- The older filing text appears truncated at the end of the forward-looking statements section, limiting full comparison of that section
- Page number references in the newer filing differ from older filing (54 vs 64 for Risk Factors), reflecting document structure changes
- Some detailed comparative language analysis may be limited by text truncation in the source documents provided
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 1 open-market sale by insiders in the last 90 days.
- Last 90 days0 buys · 1 sell ($12741) — 1 selling insider
- Last 180 days0 buys · 1 sell ($12741) — 1 selling insider
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-02. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about DD's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 4 matched disclosures for DD from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Short interest (FINRA)
DD had 5,204,615 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
DD had 3.85% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.91 days to cover at the same settlement.
- Reported short interest (shares) 5,204,615
- Short interest (% of shares outstanding) 3.85%
- Prior settlement (shares) 4,200,075
- Reported change 23.92%
- Days to cover (reported) 2.91
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare DD vs…
DuPont is found in…
DD ranks in…
Frequently asked questions
What does DuPont (DD) do?
DuPont de Nemours, Inc. is a global materials science company that has recently undergone a major portfolio transformation, divesting its electronics, semiconductor, and aramid fiber businesses. The company focuses on developing science-based solutions across various industrial, construction, and consumer applications. Following these divestitures, DuPont continues to manage legacy liabilities, most notably those related to per- and polyfluoroalkyl substances (PFAS).
What sector is DuPont (DD) in?
DuPont (DD) is classified in the Materials sector. Its industry is Specialty Chemicals. It trades on NYSE.
Does DD pay a dividend?
Yes — DuPont (DD) pays a dividend, with an indicated yield of about 2.01% and 1-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-08-24). Informational only — not financial advice.
Who are DuPont's (DD) competitors?
Notable peers of DuPont (DD) include Corteva and The Chemours Company. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in DD?
Yes — we hold 4 matched STOCK Act disclosures for DD from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is DuPont (DD) overbought or oversold right now?
DuPont (DD) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 45, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on DD come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.